Skip to content

Clinical trials

Terminated Pulmonary Arterial Hypertension trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Terminated Country / region: United Kingdom Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20091
20101
20111
20132
20162
20172
20182
20191
20215
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Actelion4
Aerovate Therapeutics2
Biogen2
Complexa, Inc.2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Bellerophon Pulse Technologies1
Gilead Sciences1
Gossamer Bio USA, Inc.1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension25
Hypertension, Pulmonary12
Hypertension3
Cardiovascular Diseases2
Connective Tissue Diseases2
Cough2
Dizziness2
Dyspnea2
Familial Primary Pulmonary Hypertension2
Lung Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.